Coronavirus  ●  Estados Unidos  ●  Islas Malvinas  ●  Mercosur  ●  Mercosur-UE  ●  Venezuela

Moderna

18/12/2020
Política CNBC - Estados Unidos Salud Berkeley Lovelace Jr.

FDA approves second Covid vaccine for emergency use as it clears Moderna’s for U.S. distribution

21:59 - Moderna’s Covid-19 vaccine is the second approved for use in the U.S. It will bolster the number of available doses, which states desperately need to fend off the pandemic. The U.S. plans to distribute roughly 5.9 million doses of Moderna’s vaccine to 64 states, territories and major cities across the nation next week.
30/11/2020
Ciencia y Tecnología Reuters Política

Moderna files for U.S. vaccine authorization, will seek EU nod

20:01 - Moderna Inc said on Monday it has applied for U.S. emergency authorization for its COVID-19 vaccine after full results from a late-stage study showed it was 94.1% effective with no serious safety concerns.
16/11/2020
Política La Vanguardia - España Salud

La vacuna de Moderna ofrece un 94,5% de efectividad contra la Covid-19

16:54 - La Agencia Europea del Medicamento ha empezado a estudiar los resultados preliminares de la vacuna de la compañía estadounidense
22/05/2020
Política CNBC - Estados Unidos Salud Tyler Clifford

Doctor testing Moderna vaccine says it’s ‘simply mind-boggling’ that injection may be ready in 2020

18:09 - “I am cautiously optimistic” that a Covid-19 vaccine could be ready for distribution by the end of 2020, Emory University medicine professor Dr. Carlos del Rio told CNBC on Friday. His comments echo that of Dr. Anthony Fauci, who said earlier that day that the vaccine development timeline is still “intact.” “Trying to think that, a year after a virus has been identified, we will have a vaccine ready to deploy and ready to go into massive distribution, it’s simply mind-boggling to me,” del Rio said.
www.prensa.cancilleria.gob.ar es un sitio web oficial del Gobierno Argentino